US 12398379
Compositions and methods for treating ornithine transcarbamylase deficiency
granted A61KA61K48/00A61P
Quick answer
US patent 12398379 (Compositions and methods for treating ornithine transcarbamylase deficiency) held by ARCTURUS THERAPEUTICS, INC. expires Mon Aug 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ARCTURUS THERAPEUTICS, INC.
- Grant date
- Tue Aug 26 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K48/00, A61P, A61P9/00